AlphaCrest Capital Management LLC Acquires 231,592 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)

AlphaCrest Capital Management LLC grew its position in GoodRx Holdings, Inc. (NASDAQ:GDRXGet Rating) by 270.6% in the second quarter, according to its most recent filing with the SEC. The fund owned 317,178 shares of the company’s stock after acquiring an additional 231,592 shares during the period. AlphaCrest Capital Management LLC owned 0.08% of GoodRx worth $1,878,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in GDRX. Raymond James & Associates grew its position in shares of GoodRx by 24.0% during the 1st quarter. Raymond James & Associates now owns 13,806 shares of the company’s stock worth $267,000 after buying an additional 2,675 shares during the period. Commonwealth Equity Services LLC increased its holdings in GoodRx by 15.9% during the first quarter. Commonwealth Equity Services LLC now owns 26,641 shares of the company’s stock worth $514,000 after buying an additional 3,648 shares during the last quarter. Advisor Group Holdings Inc. increased its stake in shares of GoodRx by 17.6% during the 1st quarter. Advisor Group Holdings Inc. now owns 28,454 shares of the company’s stock worth $414,000 after purchasing an additional 4,265 shares during the last quarter. Keebeck Alpha LP increased its position in GoodRx by 36.1% in the second quarter. Keebeck Alpha LP now owns 17,397 shares of the company’s stock worth $103,000 after buying an additional 4,612 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its stake in GoodRx by 1,233.2% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 5,066 shares of the company’s stock valued at $30,000 after acquiring an additional 4,686 shares during the period. 39.16% of the stock is currently owned by institutional investors.

GoodRx Stock Performance

GDRX stock opened at $4.77 on Thursday. The company has a quick ratio of 10.34, a current ratio of 10.34 and a debt-to-equity ratio of 0.83. GoodRx Holdings, Inc. has a 12 month low of $3.82 and a 12 month high of $42.87. The firm’s 50-day moving average is $5.08 and its 200 day moving average is $6.23.

Analyst Ratings Changes

Several research firms have issued reports on GDRX. KeyCorp started coverage on shares of GoodRx in a research note on Thursday, September 15th. They issued a “sector weight” rating on the stock. The Goldman Sachs Group cut their price objective on shares of GoodRx from $10.00 to $8.00 and set a “neutral” rating for the company in a research note on Wednesday, November 9th. Barclays reduced their price target on GoodRx from $13.00 to $9.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 11th. JPMorgan Chase & Co. raised shares of GoodRx from an “underweight” rating to a “neutral” rating and cut their price target for the stock from $10.00 to $8.00 in a report on Friday, November 4th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on GoodRx from $9.00 to $7.00 in a research note on Thursday, November 10th. Fifteen analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $13.28.

About GoodRx

(Get Rating)

GoodRx Holdings, Inc, through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States.

Featured Stories

Want to see what other hedge funds are holding GDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GoodRx Holdings, Inc. (NASDAQ:GDRXGet Rating).

Institutional Ownership by Quarter for GoodRx (NASDAQ:GDRX)

Receive News & Ratings for GoodRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoodRx and related companies with MarketBeat.com's FREE daily email newsletter.